Testing add-on treatment to calm artery inflammation after heart procedures
Treatments studied
Part of Heart & circulation clinical trials.
This study looks at whether a comprehensive add-on treatment—starting with immune medicine and then a heart procedure when needed—can improve outcomes for people whose coronary artery disease is getting worse quickly. It focuses on cases where inflammation is likely driving new artery blockages or worsening chest pain.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re 18 or older and can be any sex
- If you can become pregnant, you must test negative on a pregnancy test before treatment
- You previously had a heart procedure to reopen arteries (PCI or CABG)
- Your heart condition is being treated with standard “secondary prevention” medicines after that procedure
- Your symptoms and heart tests show rapidly worsening reduced blood flow, and it happened within 6 months (or within 12 months if you’re on immune-suppressing medicines)
- Your recent heart scan shows new artery narrowing or re-narrowing linked to the reduced blood flow, plus evidence of inflammation
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two types of coronary artery disease: one linked to inflammation (IR-CAD) and the standard type (AS-CAD). If you have had a heart procedure and were recently hospitalized for worsening chest pain, this study may help doctors understand your condition better.
This study follows people who have both coronary artery disease (narrowed heart arteries) and signs of chronic inflammation to learn more about their condition, current treatments, and outcomes. It helps doctors understand how best to care for patients like you.
This study looks at real-world outcomes for people with narrowed heart arteries (coronary artery disease). It may include those treated with stents (PCI) or medicines. Doctors will use a special computer tool to measure the severity of blockages and track health over time.
This study follows adults who have fast, unexplained re-narrowing of a coronary stent, to better understand what causes it and how to monitor it. You may help by allowing the study team to collect medical information over time.
This study tests a new medicine called YMI024 for people with stable coronary artery disease (blockages in heart arteries) and higher than normal levels of inflammation. The drug aims to reduce inflammation and may lower the risk of future heart problems.
This trial tests whether adding a special scan to look at the fatty plaque in your arteries can help your doctor decide if you need stronger heart medication to prevent future heart attacks or strokes. If you have moderate blockages and signs of inflammation, you may be able to join.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.